- S&P 500 Futures stay firm around intraday top, rises for the second consecutive day.
- Vaccine optimism, no rate hike chatters and upbeat early signals for NFP back the bulls.
- Covid woes, China and cautious sentiment ahead of the key data tame risk-on mood.
S&P 500 Futures stay firmer around 4,200, up 0.16% intraday, during early Friday. In doing so, the risk barometer follows the US equities to the north to print a two-day uptrend amid a mostly quiet Asian session.
The Federal Reserve (Fed) policymakers’ rejection of the rate-hike fears, except for Dallas Fed President Robert Kaplan, seems the major push behind the latest market optimism. Also on the positive side could be the US and the European Union’s (EU) support to waive the coronavirus (COVID-19) vaccine patents.
It’s worth mentioning that the early signals for April employment figures for the US have been recently upbeat and hence traders stay hopeful of a strong jobs report from the world’s largest economy.
Additionally, all three benchmark indices on Wall Street closed positive for the first in a week the previous day, which in turn offers extra fuel to the S&P 500 Futures.
Meanwhile, US investment limits on Chinese companies and Beijing’s refrain from talking business to Australia weigh on the risk appetite. Also, Japan’s almost certain extension of the virus-led emergency and the global ire over China’s performance in Taiwan, Hong Kong and Xinjiang challenges the market mood.
Above all, caution ahead of the key US data and a light calendar restrict the market’s performance during early Friday. Ahead of the US data, trade numbers from China and Germany may offer intermediate moves while political headlines from the UK, the EU and the US, coupled with the covid updates, could also entertain investors.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.